Stocks and Investing Stocks and Investing
Fri, March 11, 2022

Drew Ranieri Maintained (BVS) at Buy with Decreased Target to $18 on, Mar 11th, 2022


Published on 2024-10-27 20:02:55 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Decreased Target from $20 to $18 on, Mar 11th, 2022.

Drew, nor any peers, have made any analyst calls on BVS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources